Multitarget Antibodies Investigated for Severe Nasal Polyps
Researchers are exploring the use of multitarget antibodies as a treatment for severe nasal polyps. This approach aims to address the complex inflammatory pathways involved in the condition, potentially offering improved outcomes for patients with difficult-to-treat nasal polyps. The investigation is part of ongoing efforts to develop more effective therapies for chronic nasal inflammation.
EMJ·



